These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 25496033)
1. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3. Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033 [TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β. Noh K; Kim YM; Kim YW; Kim SG Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890 [TBL] [Abstract][Full Text] [Related]
3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related]
4. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells. Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871 [TBL] [Abstract][Full Text] [Related]
5. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis. Haga S; Yimin ; Ozaki M BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800 [TBL] [Abstract][Full Text] [Related]
6. A Central Role for JNK/AP-1 Pathway in the Pro-Oxidant Effect of Pyrrolidine Dithiocarbamate through Superoxide Dismutase 1 Gene Repression and Reactive Oxygen Species Generation in Hematopoietic Human Cancer Cell Line U937. Riera H; Afonso V; Collin P; Lomri A PLoS One; 2015; 10(5):e0127571. PubMed ID: 25996379 [TBL] [Abstract][Full Text] [Related]
8. GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression. Zhang S; Pan X; Jeong H Drug Metab Dispos; 2015 May; 43(5):743-8. PubMed ID: 25725071 [TBL] [Abstract][Full Text] [Related]
9. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho. Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219 [TBL] [Abstract][Full Text] [Related]
10. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. Kong B; Zhu Y; Li G; Williams JA; Buckley K; Tawfik O; Luyendyk JP; Guo GL Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G295-302. PubMed ID: 26744468 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. Gupta S; Stravitz RT; Dent P; Hylemon PB J Biol Chem; 2001 May; 276(19):15816-22. PubMed ID: 11278771 [TBL] [Abstract][Full Text] [Related]
12. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes. Murakami T; Walczak R; Caron S; Duhem C; Vidal V; Darteil R; Staels B Biochem J; 2007 Nov; 407(3):461-9. PubMed ID: 17655523 [TBL] [Abstract][Full Text] [Related]
13. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity. Jin J; Sun X; Zhao Z; Wang W; Qiu Y; Fu X; Huang M; Huang Z Phytomedicine; 2015 Sep; 22(10):894-901. PubMed ID: 26321738 [TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding. Li G; Thomas AM; Williams JA; Kong B; Liu J; Inaba Y; Xie W; Guo GL PLoS One; 2012; 7(4):e35895. PubMed ID: 22540009 [TBL] [Abstract][Full Text] [Related]
15. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Li J; Zhang Y; Kuruba R; Gao X; Gandhi CR; Xie W; Li S Mol Pharmacol; 2011 Jul; 80(1):191-200. PubMed ID: 21511916 [TBL] [Abstract][Full Text] [Related]
16. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells. Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy. Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826 [TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver. Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064. Martínez-Fernández P; Hierro L; Jara P; Alvarez L Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]